USPSTF Recommends Amblyopia Screening for 3- to 5-Year-Olds

Share this content:
USPSTF Recommends Amblyopia Screening for 3- to 5-Year-Olds
USPSTF Recommends Amblyopia Screening for 3- to 5-Year-Olds

TUESDAY, Sept. 5, 2017 (HealthDay News) -- The U.S. Preventive Services Task Force (USPSTF) recommends screening 3- to 5-year-old children for amblyopia, although inadequate evidence is available to assess the benefits and harms of screening for children younger than 3 years. These findings form the basis of a recommendation statement published online Sept. 5 in the Journal of the American Medical Association.

Daniel E. Jonas, M.D., M.P.H., from the University of North Carolina in Chapel Hill, and colleagues conducted a systematic literature review of the evidence on screening for and treatment of amblyopia to inform development of the USPSTF recommendations.

The USPSTF concluded that the overall net benefit is moderate for children aged 3 to 5 years (B recommendation). The current evidence is inadequate for assessing the balance of benefits and harms of screening in children aged younger than 3 years (I statement).

"Screening for vision problems in children three to five years old can catch issues early and allow for them to be corrected. Often this can prevent permanent vision loss," task force member Alex R. Kemper, M.D., M.P.H., said in a statement.

Abstract/Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »